KCVSX
Price
$17.46
Change
+$0.11 (+0.63%)
Updated
Jan 17 closing price
Net Assets
258.21M
RMFCX
Price
$55.77
Change
+$0.30 (+0.54%)
Updated
Jan 17 closing price
Net Assets
103.41B
Ad is loading...

KCVSX vs RMFCX

Header iconKCVSX vs RMFCX Comparison
Open Charts KCVSX vs RMFCXBanner chart's image
Knights of Columbus Large Cap Value S
Price$17.46
Change+$0.11 (+0.63%)
VolumeN/A
Net Assets258.21M
American Funds American Mutual R3
Price$55.77
Change+$0.30 (+0.54%)
VolumeN/A
Net Assets103.41B
KCVSX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
KCVSX vs. RMFCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KCVSX is a Buy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 103B vs. KCVSX (258M). RMFCX pays higher dividends than KCVSX: RMFCX (1.69) vs KCVSX (0.99). KCVSX was incepted earlier than RMFCX: KCVSX (10 years) vs RMFCX (23 years). KCVSX is a more actively managed with annual turnover of: 37.00 vs. RMFCX (25.00). KCVSX has a lower initial minimum investment than RMFCX: KCVSX (0) vs RMFCX (250). KCVSX annual gain was more profitable for investors over the last year : 14.27 vs. RMFCX (12.43). RMFCX (37.82) and KCVSX (37.64) have equivalent 5 years return.
KCVSXRMFCXKCVSX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD3.0702.162142%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets258M103B0%
Annual Yield % from dividends0.991.6959%
Returns for 1 year14.2712.43115%
Returns for 3 years15.5012.60123%
Returns for 5 years37.6437.82100%
Returns for 10 yearsN/A65.18-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDZI5.160.23
+4.77%
CADIZ
HOOD48.152.07
+4.49%
Robinhood Markets
NERV2.230.08
+3.72%
Minerva Neurosciences
WHD63.63-0.15
-0.24%
Cactus
EOLS10.51-0.10
-0.94%
Evolus